{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:28:03Z","timestamp":1760956083235},"reference-count":56,"publisher":"Edizioni Minerva Medica","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Minerva Cardioangiol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.23736\/s0026-4725.20.05271-8","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T10:23:10Z","timestamp":1603448590000},"source":"Crossref","is-referenced-by-count":2,"title":["Relationship between angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and SARS-CoV-2 infection: where are we?"],"prefix":"10.23736","volume":"68","author":[{"given":"Fabio","family":"Infusino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Mancone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Cavarretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Frati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Biondi Zoccai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17149","reference":[{"key":"10.23736\/S0026-4725.20.05271-8_ref001","unstructured":"WHO. Coronavirus disease (COVID-19) dashboard; 2020 [Internet] Available from: https:\/\/experience.arcgis.com\/experience\/685d0ace521648f8a5beeeee1b9125cd [cited 2020, Jun 9]."},{"key":"10.23736\/S0026-4725.20.05271-8_ref002","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648"},{"key":"10.23736\/S0026-4725.20.05271-8_ref003","doi-asserted-by":"publisher","DOI":"10.1038\/nm1267"},{"key":"10.23736\/S0026-4725.20.05271-8_ref004","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0688-y"},{"key":"10.23736\/S0026-4725.20.05271-8_ref005","first-page":"219","article-title":"[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia]","volume":"43","author":"Sun ML","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.23736\/S0026-4725.20.05271-8_ref006","unstructured":"Fountain JH, Lappin SL. Physiology, Renin Angiotensin System. Treasure Island , FL: StatPearls Publishing; 2020."},{"key":"10.23736\/S0026-4725.20.05271-8_ref007","unstructured":"ACE2 angiotensin I converting enzyme 2 [Homo sapiens (human)]. NCBI; 2020 [Internet]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=59272 [cited 2020, March 14]."},{"key":"10.23736\/S0026-4725.20.05271-8_ref008","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1432869100"},{"key":"10.23736\/S0026-4725.20.05271-8_ref009","doi-asserted-by":"publisher","DOI":"10.2174\/156801605774322373"},{"key":"10.23736\/S0026-4725.20.05271-8_ref010","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-10-0045"},{"key":"10.23736\/S0026-4725.20.05271-8_ref011","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02202-13"},{"key":"10.23736\/S0026-4725.20.05271-8_ref012","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4209"},{"key":"10.23736\/S0026-4725.20.05271-8_ref013","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2019.104350"},{"key":"10.23736\/S0026-4725.20.05271-8_ref014","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.043919-0"},{"key":"10.23736\/S0026-4725.20.05271-8_ref015","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00498.2016"},{"key":"10.23736\/S0026-4725.20.05271-8_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.04.001"},{"key":"10.23736\/S0026-4725.20.05271-8_ref017","doi-asserted-by":"publisher","DOI":"10.1002\/path.1570"},{"key":"10.23736\/S0026-4725.20.05271-8_ref018","doi-asserted-by":"crossref","unstructured":"Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv 2020 [Internet]. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2020.01.26.919985v1.full [cited 2020, Jun 6].","DOI":"10.1101\/2020.01.26.919985"},{"key":"10.23736\/S0026-4725.20.05271-8_ref019","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.23.14614-14621.2005"},{"key":"10.23736\/S0026-4725.20.05271-8_ref020","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600640"},{"key":"10.23736\/S0026-4725.20.05271-8_ref021","first-page":"ahead of print","article-title":"Tobacco-Use Disparity in Gene Expression of ACE2, the Receptor of 2019-nCov.","author":"Cai G.","year":"2020","journal-title":"Preprints"},{"key":"10.23736\/S0026-4725.20.05271-8_ref022","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0147-1"},{"key":"10.23736\/S0026-4725.20.05271-8_ref023","doi-asserted-by":"publisher","DOI":"10.1038\/nature03712"},{"key":"10.23736\/S0026-4725.20.05271-8_ref024","doi-asserted-by":"publisher","DOI":"10.1177\/1470320311405557"},{"key":"10.23736\/S0026-4725.20.05271-8_ref025","doi-asserted-by":"publisher","DOI":"10.1042\/CS20060020"},{"key":"10.23736\/S0026-4725.20.05271-8_ref026","doi-asserted-by":"publisher","DOI":"10.1042\/CS20120269"},{"key":"10.23736\/S0026-4725.20.05271-8_ref027","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-011-1011-z"},{"key":"10.23736\/S0026-4725.20.05271-8_ref028","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.01.058"},{"key":"10.23736\/S0026-4725.20.05271-8_ref029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197410172911611"},{"key":"10.23736\/S0026-4725.20.05271-8_ref030","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.510461"},{"key":"10.23736\/S0026-4725.20.05271-8_ref031","doi-asserted-by":"publisher","DOI":"10.2174\/1568026043387818"},{"key":"10.23736\/S0026-4725.20.05271-8_ref032","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21656"},{"key":"10.23736\/S0026-4725.20.05271-8_ref033","unstructured":"Use of angiotensin receptor blockers such as Telmisartan, Losartsan in nCoV Wuhan Corona Virus infections - Novel mode of treatment. The BMJ; 2020 [Internet]. Available from: https:\/\/www.bmj.com\/content\/368\/bmj.m406\/rr-2 [cited 2020, Jun 14]."},{"key":"10.23736\/S0026-4725.20.05271-8_ref034","first-page":"E014","article-title":"[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia]","volume":"43","author":"Sun ML","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.23736\/S0026-4725.20.05271-8_ref035","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000124667.34652.1a"},{"key":"10.23736\/S0026-4725.20.05271-8_ref036","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00127-20"},{"key":"10.23736\/S0026-4725.20.05271-8_ref037","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.06.005"},{"key":"10.23736\/S0026-4725.20.05271-8_ref038","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8"},{"key":"10.23736\/S0026-4725.20.05271-8_ref039","doi-asserted-by":"crossref","unstructured":"Re: Preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19. The BMJ; 2020 [Internet]. Available from: https:\/\/www.bmj.com\/content\/368\/bmj.m810\/rr-2 [cited 2020, Jun 14].","DOI":"10.1136\/bmj.m810"},{"key":"10.23736\/S0026-4725.20.05271-8_ref040","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007621"},{"key":"10.23736\/S0026-4725.20.05271-8_ref041","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317134"},{"key":"10.23736\/S0026-4725.20.05271-8_ref042","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008975"},{"key":"10.23736\/S0026-4725.20.05271-8_ref043","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006923"},{"key":"10.23736\/S0026-4725.20.05271-8_ref044","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpaa096"},{"key":"10.23736\/S0026-4725.20.05271-8_ref045","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1746200"},{"key":"10.23736\/S0026-4725.20.05271-8_ref046","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1924"},{"key":"10.23736\/S0026-4725.20.05271-8_ref047","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15143"},{"key":"10.23736\/S0026-4725.20.05271-8_ref048","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1624"},{"key":"10.23736\/S0026-4725.20.05271-8_ref049","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.052"},{"key":"10.23736\/S0026-4725.20.05271-8_ref050","unstructured":"Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19. ClinicalTrials.gov; 2020 [Internet]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04335136 [cited 2020, Jun 14]."},{"key":"10.23736\/S0026-4725.20.05271-8_ref051","unstructured":"ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. ESC; 2020 [Internet]. Available from: https:\/\/www.escardio.org\/Education\/COVID-19-and-Cardiology\/ESC-COVID-19-Guidance [cited 2020, Jun 14]."},{"key":"10.23736\/S0026-4725.20.05271-8_ref052","unstructured":"HFSA\/ACC\/AHA Statement Addresses Concerns Re. Using RAAS Antagonists in COVID-19. American College of Cardiology; 2020 [Internet]. Available from: https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2020\/03\/17\/08\/59\/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19 [cited 2020, Jun 14]."},{"key":"10.23736\/S0026-4725.20.05271-8_ref053","unstructured":"ESH statement on COVID-19. ESH; 2020 [Internet]. Available from: https:\/\/www.eshonline.org\/spotlights\/esh-statement-covid-19\/ [cited 2020, Mar 12]."},{"key":"10.23736\/S0026-4725.20.05271-8_ref054","unstructured":"Farmaci antiipertensivi e rischio di COVID-19: il comunicato della SIIA. SIA; 2020 [Internet]. Available from: https:\/\/siia.it\/notizie-siia\/farmaci-antiipertensivi-e-rischio-di-covid-19-il-comunicato-della-siia\/ [cited 2020, Jun 6]."},{"key":"10.23736\/S0026-4725.20.05271-8_ref055","unstructured":"Documento della SIC: guida clinica covid-19 per cardiologi. SIC; 2020 [Internet].Available from:https:\/\/www.sicardiologia.it\/public\/Documento-SIC-COVID-19.pdf [cited 2020, Jun 14]."},{"key":"10.23736\/S0026-4725.20.05271-8_ref056","unstructured":"Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers. ESC; 2020 [Internet]. Available from: https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension-(CHT)\/News\/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang [cited 2020, Jun 14]."}],"container-title":["Minerva Cardioangiologica"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R05Y2020N04A0339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T10:25:09Z","timestamp":1603448709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R05Y2020N04A0339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":56,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.23736\/s0026-4725.20.05271-8","relation":{},"ISSN":["0026-4725","1827-1618"],"issn-type":[{"value":"0026-4725","type":"print"},{"value":"1827-1618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}